These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24217961)

  • 1. Successful isavuconazole salvage therapy in a patient with invasive mucormycosis.
    Ervens J; Ghannoum M; Graf B; Schwartz S
    Infection; 2014 Apr; 42(2):429-32. PubMed ID: 24217961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.
    Gebremariam T; Alkhazraji S; Baldin C; Kovanda L; Wiederhold NP; Ibrahim AS
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isavuconazole As Successful Salvage Therapy for Mucormycosis in Pediatric Patients.
    Ashkenazi-Hoffnung L; Bilavsky E; Levy I; Grisaru G; Sadot E; Ben-Ami R; Novikov A; Fischer S; Nahum E; Scheuerman O
    Pediatr Infect Dis J; 2020 Aug; 39(8):718-724. PubMed ID: 32251256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
    Gebremariam T; Wiederhold NP; Alqarihi A; Uppuluri P; Azie N; Edwards JE; Ibrahim AS
    J Antimicrob Chemother; 2017 Feb; 72(2):462-466. PubMed ID: 27798213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.
    Cornu M; Bruno B; Loridant S; Navarin P; François N; Lanternier F; Amzallag-Bellenger E; Dubos F; Mazingue F; Sendid B
    BMC Pharmacol Toxicol; 2018 Dec; 19(1):81. PubMed ID: 30522521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
    Miceli MH; Kauffman CA
    Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isavuconazole therapy protects immunosuppressed mice from mucormycosis.
    Luo G; Gebremariam T; Lee H; Edwards JE; Kovanda L; Ibrahim AS
    Antimicrob Agents Chemother; 2014; 58(4):2450-3. PubMed ID: 24492363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isavuconazole treatment of a patient with disseminated mucormycosis.
    Peixoto D; Gagne LS; Hammond SP; Gilmore ET; Joyce AC; Soiffer RJ; Marty FM
    J Clin Microbiol; 2014 Mar; 52(3):1016-9. PubMed ID: 24403304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of posaconazole in the treatment of infective rhinocerebral mucormycosis.
    Kulendra K; Habibi M; Butler C; Clarke P; Howard D
    J Laryngol Otol; 2010 Dec; 124(12):1314-7. PubMed ID: 20388246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
    Marty FM; Ostrosky-Zeichner L; Cornely OA; Mullane KM; Perfect JR; Thompson GR; Alangaden GJ; Brown JM; Fredricks DN; Heinz WJ; Herbrecht R; Klimko N; Klyasova G; Maertens JA; Melinkeri SR; Oren I; Pappas PG; Ráčil Z; Rahav G; Santos R; Schwartz S; Vehreschild JJ; Young JH; Chetchotisakd P; Jaruratanasirikul S; Kanj SS; Engelhardt M; Kaufhold A; Ito M; Lee M; Sasse C; Maher RM; Zeiher B; Vehreschild MJGT;
    Lancet Infect Dis; 2016 Jul; 16(7):828-837. PubMed ID: 26969258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
    Jenks JD; Salzer HJ; Prattes J; Krause R; Buchheidt D; Hoenigl M
    Drug Des Devel Ther; 2018; 12():1033-1044. PubMed ID: 29750016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful posaconazole salvage therapy for rhinocerebral mucormycosis in a child with leukemia. Review of the literature.
    Ojeda-Diezbarroso K; Aguilar-Rascón J; Jiménez-Juárez RN; Moreno-Espinosa S; Reséndiz-Sánchez J; Romero-Zamora JL
    Rev Iberoam Micol; 2019; 36(3):160-164. PubMed ID: 31563327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae.
    Kok J; Gilroy N; Halliday C; Lee OC; Novakovic D; Kevin P; Chen S
    J Infect; 2007 Sep; 55(3):e33-6. PubMed ID: 17624436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK.
    Bagshaw E; Kuessner D; Posthumus J; Escrig C; Blackney M; Heimann SM; Cornely OA
    Future Microbiol; 2017 May; 12():515-525. PubMed ID: 28191796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of invasive mucormycosis with isavuconazole in pediatric patients.
    Barg AA; Malkiel S; Bartuv M; Greenberg G; Toren A; Keller N
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27281. PubMed ID: 29932282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents.
    Chitasombat MN; Kontoyiannis DP
    Curr Opin Infect Dis; 2016 Aug; 29(4):340-5. PubMed ID: 27191199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhinocerebral mucormycosis diagnosis by aspiration cytology.
    Deshpande AH; Munshi MM
    Diagn Cytopathol; 2000 Aug; 23(2):97-100. PubMed ID: 10888753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.
    Shirley M; Scott LJ
    Drugs; 2016 Nov; 76(17):1647-1657. PubMed ID: 27766566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.
    Ville S; Talarmin JP; Gaultier-Lintia A; Bouquié R; Sagan C; Le Pape P; Giral M; Morio F
    Exp Clin Transplant; 2016 Feb; 14(1):96-9. PubMed ID: 25275881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.